Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:1405 (Glytoucan)

Id:011e1c1e-cd5c-51b8-8e27-3539a083989f

Glytoucan:G47760VS

Results found

Linked to

	Label	Description
	label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 has canonical residue n-glycan a-l-fucp 15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 has glycosequence GLYGEN.GLYCOSEQUENCE:G47760VS-GLYCOSEQ00121263 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 has glycosequence GLYGEN.GLYCOSEQUENCE:G47760VS-GLYCOSEQ00121261 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1405 has canonical residue n-glycan core d-glcnac a Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 has canonical residue n-glycan a-l-fucp 15

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 has glycosequence GLYGEN.GLYCOSEQUENCE:G47760VS-GLYCOSEQ00121263 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 has glycosequence GLYGEN.GLYCOSEQUENCE:G47760VS-GLYCOSEQ00121261 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1405 has canonical residue n-glycan core d-glcnac a

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.